Danaher Corp DHR:NYSE

RT Quote | Last NYSE Arca, VOL From CTA | USD

Last | 10:25 AM EDT

261.70

+0.30 (+0.11%)

Volume

560,438

52 week range

182.09 - 268.98

Open262.18
Day High262.85
Day Low260.85
Prev Close261.40
52 Week High268.98
52 Week High Date05/22/24
52 Week Low182.09
52 Week Low Date10/30/23

Key Stats

Market Cap193.838B
Shares Out740.69M
10 Day Average Volume2.54M
Dividend1.08
Dividend Yield0.41%
Beta0.86
YTD % Change13.26

KEY STATS

Open262.18
Day High262.85
Day Low260.85
Prev Close261.40
52 Week High268.98
52 Week High Date05/22/24
52 Week Low182.09
52 Week Low Date10/30/23
Market Cap193.838B
Shares Out740.69M
10 Day Average Volume2.54M
Dividend1.08
Dividend Yield0.41%
Beta0.86
YTD % Change13.26

RATIOS/PROFITABILITY

EPS (TTM)5.95
P/E (TTM)43.95
Fwd P/E (NTM)35.49
EBITDA (TTM)7.441B
ROE (TTM)7.88%
Revenue (TTM)23.737B
Gross Margin (TTM)58.39%
Net Margin (TTM)17.14%
Debt To Equity (MRQ)33.99%

EVENTS

Earnings Date07/23/2024(est)
Ex Div Date06/28/2024
Div Amount0.27
Split Date-
Split Factor-

Latest On Danaher Corp

Here are the portfolio's top 5 performers in a record-setting week for stocksMay 18, 2024CNBC.com
Danaher shows how sticking with a troubled stock of a good company can pay offMay 15, 2024CNBC.com
It's no surprise to see Amazon shares lower after cloud CEO shakeupMay 14, 2024CNBC.com
Tuesday, May, 14, 2024: Jim Cramer says this surging meme stock has no 'game plan'May 14, 2024CNBC.com
Stock spinoffs are one of the hottest trades going this year. How to participateMay 7, 2024CNBC.com

Content From Our Affiliates

Danaher launches collaboration with John Hopkins UniversityMay 9, 2024TipRanks
Danaher Announces Quarterly DividendMay 7, 2024TipRanks
Danaher call volume above normal and directionally bullishMay 1, 2024TipRanks
Fly Insider: Zura Bio, Google among week’s notable insider tradesApril 29, 2024TipRanks
ABT, DHR, DXCM: Which “Strong Buy” Healthcare Stock Has More Upside?April 26, 2024TipRanks

Profile

Danaher Corporation is a global life sciences and diagnostics innovator. The Company operates through three business segments: Biotechnology, Life Sciences and Diagnostics. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a broad range of equipment, consumables and services that are primarily used by customers to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life...

Steven Rales

Chairman of the Board

Rainer Blair

President, Chief Executive Officer, Director

Matthew McGrew

Chief Financial Officer, Executive Vice President

Joakim Weidemanis

Executive Vice President

Christopher Riley

Executive Vice President

Address

2200 Pennsylvania Ave NW Ste 800W

Washington, DC

20037-1731

United States

https://www.danaher.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
ABT Abbott Laboratories	103.63	-0.60	-0.58%
SYK Stryker Corp	333.21	+3.09	+0.94%
MDT Medtronic PLC	81.92	+0.54	+0.66%
TMO Thermo Fisher Scientific Inc	582.10	-2.93	-0.50%
BSX Boston Scientific Corp	75.72	+1.34	+1.81%